MQS Management LLC Makes New $824,000 Investment in Amdocs Limited $DOX

MQS Management LLC bought a new stake in Amdocs Limited (NASDAQ:DOX) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 10,043 shares of the technology company’s stock, valued at approximately $824,000. Amdocs makes up 0.5% of MQS Management LLC’s holdings, making the stock its 27th largest position.

A number of other hedge funds have also recently modified their holdings of the stock. Amundi lifted its position in Amdocs by 73.0% in the first quarter. Amundi now owns 13,778 shares of the technology company’s stock valued at $1,217,000 after acquiring an additional 5,816 shares during the last quarter. Millennium Management LLC increased its position in shares of Amdocs by 458.3% during the first quarter. Millennium Management LLC now owns 67,047 shares of the technology company’s stock worth $6,135,000 after purchasing an additional 55,038 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Amdocs by 12.6% during the first quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company’s stock worth $30,300,000 after purchasing an additional 37,087 shares in the last quarter. Empowered Funds LLC lifted its holdings in shares of Amdocs by 12.0% in the 1st quarter. Empowered Funds LLC now owns 15,979 shares of the technology company’s stock valued at $1,462,000 after purchasing an additional 1,709 shares during the last quarter. Finally, Jane Street Group LLC boosted its position in shares of Amdocs by 195.4% in the 1st quarter. Jane Street Group LLC now owns 115,929 shares of the technology company’s stock valued at $10,608,000 after purchasing an additional 76,683 shares during the period. 92.02% of the stock is owned by hedge funds and other institutional investors.

Amdocs Stock Down 0.3%

DOX stock opened at $73.13 on Wednesday. The stock has a market capitalization of $7.89 billion, a PE ratio of 14.15, a price-to-earnings-growth ratio of 1.30 and a beta of 0.40. The company has a fifty day moving average of $80.07 and a 200-day moving average of $82.08. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.17 and a current ratio of 1.06. Amdocs Limited has a one year low of $70.24 and a one year high of $95.41.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The firm had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.15 billion. During the same period in the prior year, the company posted $1.66 earnings per share. The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, analysts expect that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.569 per share. This is an increase from Amdocs’s previous quarterly dividend of $0.53. This represents a $2.28 dividend on an annualized basis and a yield of 3.1%. The ex-dividend date of this dividend is Tuesday, March 31st. Amdocs’s payout ratio is presently 43.91%.

Analysts Set New Price Targets

Several research analysts have commented on the company. Barclays cut their price target on Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 4th. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Wolfe Research reiterated a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Bank of America decreased their price target on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research note on Wednesday, November 12th. Finally, Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $92.33.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.